Sathianathen, N. J., Dahm, P., Brown, S. J., Oestreich, M., Gupta, S., Konety, B. R., & Kunath, F. (2019). Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone‐sensitive prostate cancer. Cochrane Database Syst Rev.
Citação norma ChicagoSathianathen, Niranjan J., Philipp Dahm, Sarah Jane Brown, Makinna Oestreich, Shilpa Gupta, Badrinath R. Konety, and Frank Kunath. "Abiraterone Acetate in Combination With Androgen Deprivation Therapy Compared to Androgen Deprivation Therapy Only for Metastatic Hormone‐sensitive Prostate Cancer." Cochrane Database Syst Rev 2019.
ציטוט MLASathianathen, Niranjan J., et al. "Abiraterone Acetate in Combination With Androgen Deprivation Therapy Compared to Androgen Deprivation Therapy Only for Metastatic Hormone‐sensitive Prostate Cancer." Cochrane Database Syst Rev 2019.